The elevated CREB5 promoted cellular proliferation in hepatocellular carcinoma, cell invasion in ovarian cancer, and resistance to androgen-receptor antagonists in prostate cancer22–24. The gene discussed is AR; the disease is hepatocellular carcinoma.